跳至主要内容
临床试验/TCTR20221129001
TCTR20221129001已完成1 期

Clinical Effects of Kale Cultivated in Vertical Hydroponic System on Health and Nutritional Status among Adults with Metabolic Syndrome : A Randomized Double Blind Placebo-controlled Trial

Program Management Unit for Competitiveness Enhancement (PMU-C)0 个研究点目标入组 97 人开始时间: 2022年11月29日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
97

研究概览

简要总结

Consumption of fresh kale and kale-derived functional ingredient supplements significantly improved lipid profiles. Specifically, there was a notable reduction in total cholesterol and LDL-C levels, accompanied by a significant increase in HDL-C levels, particularly in the group receiving kale-derived supplements. Additionally, these interventions contributed to a reduced risk of cardiovascular events and showed a positive trend toward improvement in chronic low-grade inflammation and antioxidant status.

研究设计

研究类型
Interventional

入排标准

年龄范围
25 Years 至 59 Years(—)
性别
All

入选标准

  • 1.) Male or female adults aged between 25-59 years old who lives in Bangkok and the vicinity area.
  • 2.) There are at risk of metabolic syndrome as follows;
  • 2.1 Waist circumference more than or equal to 90 cm for men, more than or equal to 80 cm for women, or Body Mass Index (BMI) more than or equal to 23 kg per m2, and or
  • 2.2 Blood pressure more than 130/85 mm Hg, and or
  • 2.3 Fasting blood results
  • - Fasting blood sugar above 100 mg / dL, and or
  • - Total cholesterol over 199 mg /dL, and or
  • - Triglyceride above 150 mg /dL, and or
  • - LDL-C over 130 mg/dl
  • 3) Consent to participate in the study.

排除标准

  • 1. Diagnosed to be NCDs or taking medications such as hypertension, diabetes, liver disease, chronic kidney disease, cardiovascular disease (CVD), cancer, hyper/hypothyroidism, etc.
  • 2. Diagnosed to be GI diseases or GI symptoms such as maldigestion and malabsorption
  • 3. Unusual eating patterns such as weight reduction diet, vegetarian diet, vegan diet, etc.
  • 4. Individuals who are using dietary supplements, herbal products, and hormones that effected to blood pressure and/or lipid profiles.
  • 5. Presentation of any inflammation or infection
  • 6. Currently smoking or alcohol drinking
  • 7. Pregnant and lactating women

研究者

发起方
Program Management Unit for Competitiveness Enhancement (PMU-C)

相似试验